Whalegun
Lobbying

Accesso Biologics's latest lobbying report covers Q2 2026, at $70K. The four quarters Q3 2025–Q2 2026 total $280K. Its first report covers Q2 2024; the issues it reports most are Health Issues.

Accesso Biologics

Latest quarter
$70K
Q2 2026 · 1 reports
Last 12 months
$280K
Last 4 quarters
vs last quarter
0.0%
Q2 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

Accesso Biologics lobbying by quarter
Accesso Biologics lobbying by quarter
QuarterAmountReports
Q2 2024$10K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$70K1
Q4 2025$70K1
Q1 2026$70K1
Q2 2026$70K1

Policy issues the reports name

  • Health issues9 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Health & Human Services, Dept of (HHS)1 reports
  • Homeland Security, Dept of (DHS)1 reports

Firms it paid

Firm
Michael Best Strategies$450K9 quarters

Former officials lobbying for it

Former position
NINIO FETALVODir of Strategic Communications, Deputy Dir of Communications, Centers for Medicare & Medicaid Services, U.S. Dept of Health & Human Services; Communications Advisor, Associate Advisor, Assistant Press Secretary, Executive Office of the PresidentQ3 2025

Lobbying reports

Filed by
07/20for Q2Michael Best Strategies$70K
04/20for Q1Michael Best Strategies$70K
01/20for Q4 2025Michael Best Strategies$70K
25/10/20for Q3 2025Michael Best Strategies$70K
25/07/21for Q2 2025Michael Best Strategies$40K
25/04/21for Q1 2025Michael Best Strategies$40K
25/03/07for Q4 2024Michael Best Strategies$40K
25/03/07for Q3 2024Michael Best Strategies$40K
25/03/07for Q2 2024Michael Best Strategies$10K
25/02/05for Q4 2024Michael Best Strategies$30K
25/01/22for Q2 2024Michael Best StrategiesUnder $5,000